Cytosorbents (CTSO) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CTSO Stock Alerts $0.88 +0.07 (+8.65%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cytosorbents Short Interest DataCurrent Short Volume1,620,000 sharesPrevious Short Volume1,670,000 sharesChange Vs. Previous Month-2.99%Dollar Volume Sold Short$1.54 millionShort Interest Ratio / Days to Cover10.8Last Record DateMarch 31, 2024Outstanding Shares54,294,000 sharesPercentage of Shares Shorted2.98%Today's Trading Volume108,104 sharesAverage Trading Volume156,206 sharesToday's Volume Vs. Average69% Short Selling Cytosorbents ? Sign up to receive the latest short interest report for Cytosorbents and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTSO Short Interest Over TimeCTSO Days to Cover Over TimeCTSO Percentage of Float Shorted Over Time Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy Cytosorbents Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,620,000 shares $1.54 million -3.0%N/A10.8 $0.95 3/15/20241,670,000 shares $1.47 million -2.9%N/A5.7 $0.88 2/29/20241,720,000 shares $1.65 million -1.7%N/A5 $0.96 2/15/20241,750,000 shares $1.77 million -2.8%N/A5 $1.01 1/31/20241,800,000 shares $1.82 million -17.1%N/A5 $1.01 1/15/20242,170,000 shares $2.16 million +7.4%N/A6.2 $0.99 Get the Latest News and Ratings for CTSO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytosorbents and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,020,000 shares $2.24 million +8.6%N/A6.4 $1.11 12/15/20231,860,000 shares $3.18 million -0.5%N/A11.9 $1.71 11/30/20231,870,000 shares $2.24 million +11.3%4.9%18.8 $1.20 11/15/20231,680,000 shares $1.97 million +3.1%4.4%19 $1.17 10/31/20231,630,000 shares $2.51 million +0.6%4.3%23.5 $1.54 10/15/20231,620,000 shares $2.77 million +21.8%4.2%23.7 $1.71 9/30/20231,330,000 shares $2.50 million +9.0%3.5%18.3 $1.88 9/15/20231,220,000 shares $2.42 million +19.6%3.2%18.5 $1.98 8/31/20231,020,000 shares $2.63 million +12.4%2.7%16.8 $2.58 8/15/2023907,700 shares $2.53 million +16.8%2.4%15.7 $2.79 7/31/2023777,300 shares $2.77 million 0.0%2.0%12 $3.57 7/15/2023777,400 shares $2.72 million -10.2%2.0%11.3 $3.50 6/30/2023866,100 shares $3.11 million +1.7%2.3%13.6 $3.59 6/15/2023851,500 shares $3.04 million +5.0%2.2%14.5 $3.57 5/31/2023810,900 shares $2.41 million +1.3%2.1%13.3 $2.97 5/15/2023800,600 shares $2.65 million +19.7%2.1%11 $3.31 4/30/2023669,100 shares $1.64 million +14.1%1.8%8 $2.45 4/15/2023586,200 shares $1.84 million -9.0%1.5%6.4 $3.14 3/31/2023644,000 shares $2.17 million -9.7%1.7%6.8 $3.37 3/15/2023712,900 shares $2.28 million +6.9%1.9%5.7 $3.20 2/28/2023666,800 shares $2.05 million +1.4%1.7%4.9 $3.08 2/15/2023657,600 shares $2.29 million -1.2%1.7%5.1 $3.48 1/31/2023665,300 shares $1.90 million +22.5%1.7%4.9 $2.86 1/15/2023543,000 shares $1.23 million +3.4%1.4%3 $2.27 12/30/2022525,000 shares $813,750.00 -16.1%1.4%3 $1.55 12/15/2022625,900 shares $726,044.00 -10.3%1.6%3.8 $1.16 11/30/2022697,500 shares $976,500.00 +2.7%1.8%4.3 $1.40 11/15/2022679,000 shares $1.04 million +33.1%1.8%4 $1.53 10/31/2022510,200 shares $954,074.00 -2.6%1.3%2.6 $1.87 10/15/2022523,900 shares $833,001.00 -10.4%1.4%3.9 $1.59 9/30/2022584,400 shares $794,784.00 -23.6%1.5%4.3 $1.36 9/15/2022765,200 shares $1.47 million +5.5%2.0%3.6 $1.92 8/31/2022725,500 shares $1.38 million +4.5%1.9%3.1 $1.90 8/15/2022694,100 shares $1.32 million -2.6%1.8%2.6 $1.90Putin and other countries have a plan (Ad)Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy CTSO Short Interest - Frequently Asked Questions What is Cytosorbents' current short interest? Short interest is the volume of Cytosorbents shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 1,620,000 shares of CTSO short. Learn More on Cytosorbents' current short interest. What is a good short interest ratio for Cytosorbents? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTSO shares currently have a short interest ratio of 11.0. Learn More on Cytosorbents's short interest ratio. Is Cytosorbents' short interest increasing or decreasing? Cytosorbents saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 1,620,000 shares, a decline of 3.0% from the previous total of 1,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cytosorbents' short interest compare to its competitors? Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Cytosorbents: Carmell Co. (0.11%), Daxor Co. (0.35%), Lucid Diagnostics Inc. (3.81%), SeaStar Medical Holding Co. (6.83%), Beyond Air, Inc. (9.71%), Apyx Medical Co. (2.49%), Co-Diagnostics, Inc. (1.59%), DarioHealth Corp. (4.62%), Spectral AI, Inc. (2.55%), LENSAR, Inc. (0.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Cytosorbents stock? Short selling CTSO is an investing strategy that aims to generate trading profit from Cytosorbents as its price is falling. CTSO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytosorbents? A short squeeze for Cytosorbents occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTSO, which in turn drives the price of the stock up even further. How often is Cytosorbents' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTSO, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CTCX Short Interest DXR Short Interest LUCD Short Interest ICU Short Interest XAIR Short Interest APYX Short Interest CODX Short Interest DRIO Short Interest MDAI Short Interest LNSR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTSO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings